Article
Performance Evaluation of a Custom Myeloid Assay on the Genexus Integrated Sequencer from a Wide Spectrum of Clinical Variants.
The Journal of molecular diagnostics : JMD - 1 Sept 2026
Dina Michelle A, Blommel Joseph H, Balan Jagadheshwar, Sankaranarayanan Saranya, Burke Jennifer E, Sedova Marina, Jianjun Jim, Jerde Calvin R, Henry Justin N, Voss Jesse S, Klee Eric W, Kipp Benjamin R, Sherlock Jon, Sadis Seth, Viswanatha David S, Murphy Stephen J
Abstract excerpt
A custom Genexus myeloid assay (CMA) underwent a technical evaluation for detection of variants from both DNA and RNA in a single assay format. The custom assay was initially verified with commercial DNA and RNA controls containing known myeloid variants. Seventy-five patient specimens with various DNA and RNA variants were selected for replicate testing. The CMA generated consistent data on two Genexus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.